Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Recruiting now · Not applicable
Conditions studied: Breast Cancer, Colorectal Cancer (CRC), Prostate Cancer, Neoadjuvant Therapy, Adjuvant Therapy
In brief
Summary Reducing sedentary behavior during treatment is important to reduce the risk of future health problems in individuals undergoing cancer treatment. Therefore, the goal of this project is with a multicenter randomised controlled design investigate whether a digital support intervention during ongoing neo- or adjuvant cancer treatment for breast, prostate or colon cancer is effective in reducing sedentary lifestyle and improving well-being in the short and long term.
Key facts
- Study ID
- NCT06719206
- Run by
- Mälardalen University
- People needed
- 172
- Starts
- 2025-03-01
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2026-01-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Individuals diagnosed with breast, prostate, or colorectal cancer planned for or resently started neo- or adjuvant treatment (e.g. chemotherapy, radiotherapy, endocrine treatment) at the hospitals in Uppsala and Västerås, Sweden.
You may not qualify if…
- Individuals diagnosed with dementia.
- Individuals diagnosed with severe psychiatric disease.
- Individuals with severe loss of vision, or communicative ability.
- Individuals who cannot walk independently indoors with or without a walking aid.
- Individuals completed treatment for other cancer diseases less than 12 months ago or not recovered from previous cancer treatment.
Where it is running
- Akademiska sjukhuset — Uppsala, Sweden (enrolling)
- Västmanlands sjukhus — Västerås, Sweden (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.